NM_147127.5:c.1730T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_147127.5(EVC2):​c.1730T>C​(p.Met577Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0017 in 1,612,242 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M577I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0053 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 18 hom. )

Consequence

EVC2
NM_147127.5 missense

Scores

3
11
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 4.95

Publications

5 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, Myriad Women's Health, Laboratory for Molecular Medicine

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_147127.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010639936).
BP6
Variant 4-5628715-A-G is Benign according to our data. Variant chr4-5628715-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 349080.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00531 (799/150466) while in subpopulation AFR AF = 0.0155 (628/40410). AF 95% confidence interval is 0.0145. There are 7 homozygotes in GnomAd4. There are 398 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147127.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
NM_147127.5
MANE Select
c.1730T>Cp.Met577Thr
missense
Exon 12 of 22NP_667338.3
EVC2
NM_001166136.2
c.1490T>Cp.Met497Thr
missense
Exon 12 of 22NP_001159608.1Q86UK5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
ENST00000344408.10
TSL:1 MANE Select
c.1730T>Cp.Met577Thr
missense
Exon 12 of 22ENSP00000342144.5Q86UK5-1
EVC2
ENST00000310917.6
TSL:1
c.1490T>Cp.Met497Thr
missense
Exon 12 of 22ENSP00000311683.2Q86UK5-2
EVC2
ENST00000475313.5
TSL:1
n.1490T>C
non_coding_transcript_exon
Exon 12 of 23ENSP00000431981.1A0A0C4DGE7

Frequencies

GnomAD3 genomes
AF:
0.00529
AC:
796
AN:
150348
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0155
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00551
Gnomad ASJ
AF:
0.00404
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000838
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0223
Gnomad NFE
AF:
0.000736
Gnomad OTH
AF:
0.00632
GnomAD2 exomes
AF:
0.00231
AC:
582
AN:
251416
AF XY:
0.00196
show subpopulations
Gnomad AFR exome
AF:
0.0163
Gnomad AMR exome
AF:
0.00370
Gnomad ASJ exome
AF:
0.00486
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000905
Gnomad OTH exome
AF:
0.00424
GnomAD4 exome
AF:
0.00132
AC:
1934
AN:
1461776
Hom.:
18
Cov.:
31
AF XY:
0.00131
AC XY:
951
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.0164
AC:
550
AN:
33478
American (AMR)
AF:
0.00373
AC:
167
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00467
AC:
122
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000348
AC:
30
AN:
86258
European-Finnish (FIN)
AF:
0.0000563
AC:
3
AN:
53324
Middle Eastern (MID)
AF:
0.0226
AC:
130
AN:
5764
European-Non Finnish (NFE)
AF:
0.000676
AC:
752
AN:
1112004
Other (OTH)
AF:
0.00298
AC:
180
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
99
198
298
397
496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00531
AC:
799
AN:
150466
Hom.:
7
Cov.:
32
AF XY:
0.00542
AC XY:
398
AN XY:
73464
show subpopulations
African (AFR)
AF:
0.0155
AC:
628
AN:
40410
American (AMR)
AF:
0.00551
AC:
83
AN:
15076
Ashkenazi Jewish (ASJ)
AF:
0.00404
AC:
14
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5064
South Asian (SAS)
AF:
0.000838
AC:
4
AN:
4772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10492
Middle Eastern (MID)
AF:
0.0240
AC:
7
AN:
292
European-Non Finnish (NFE)
AF:
0.000736
AC:
50
AN:
67904
Other (OTH)
AF:
0.00625
AC:
13
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
38
77
115
154
192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00236
Hom.:
6
Bravo
AF:
0.00626
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.00234
EpiControl
AF:
0.00219

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
2
not specified (2)
-
-
1
Ellis-van Creveld syndrome (1)
-
-
1
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.067
T
BayesDel_noAF
Pathogenic
0.14
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.75
D
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.62
T
MetaRNN
Benign
0.011
T
MetaSVM
Uncertain
0.086
D
MutationAssessor
Uncertain
2.5
M
PhyloP100
4.9
PrimateAI
Uncertain
0.68
T
PROVEAN
Uncertain
-3.4
D
REVEL
Pathogenic
0.66
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.017
D
Varity_R
0.59
gMVP
0.38
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs113869406;
hg19: chr4-5630442;
COSMIC: COSV107399036;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.